Literature DB >> 17216936

The potential role of Rattus rattus in enzootic cycle of Rift Valley Fever in Egypt. 1-Detection of RVF antibodies in R. rattus blood samples by both enzyme linked immuno sorbent assay (ELISA) and immuno-diffusion technique (ID).

B Z Youssef1, H A Donia.   

Abstract

Three hundreds of Rattus rattus (R. rattus) were trapped from 3 different governorates of Egypt (one hundred each), blood samples were withdrawal and subjected for detection of anti-RVF antibodies by both ELISA and ID techniques. The prevalence rate of antibodies by ELISA were 88 (29.33%) positive out of 300 tested blood samples, the highest rate was in Behira governorate 36 (36%) and the lowest one was in Alexandria governorate 22 (22%) while it was 30 (30%) in Minia governorate. But when ID technique was applied, it gave only 18 (6%) positive samples out of 300 tested blood samples with the highest rate in Behira and Minia governorates (8%) and it was only (2%) in Alexandria governorate. Our study suggests that these R. rattus make possible candidate as intermediate host in the maintenance cycle of RVF in Egypt.

Entities:  

Mesh:

Year:  2001        PMID: 17216936

Source DB:  PubMed          Journal:  J Egypt Public Health Assoc        ISSN: 0013-2446


  3 in total

Review 1.  Livestock Challenge Models of Rift Valley Fever for Agricultural Vaccine Testing.

Authors:  Andrea Louise Kroeker; Shawn Babiuk; Bradley S Pickering; Juergen A Richt; William C Wilson
Journal:  Front Vet Sci       Date:  2020-05-27

Review 2.  Epidemiology of Mosquito-Borne Viruses in Egypt: A Systematic Review.

Authors:  Yuan Fang; Emad I M Khater; Jing-Bo Xue; Enas H S Ghallab; Yuan-Yuan Li; Tian-Ge Jiang; Shi-Zhu Li
Journal:  Viruses       Date:  2022-07-20       Impact factor: 5.818

3.  Absence of Rift Valley fever virus in wild small mammals, Madagascar.

Authors:  Marie-Marie Olive; Nadia Razafindralambo; Tony Andrianaivo Barivelo; Jean-Théophile Rafisandratantsoa; Voahangy Soarimalala; Steven M Goodman; Pierre E Rollin; Jean-Michel Heraud; Jean-Marc Reynes
Journal:  Emerg Infect Dis       Date:  2013-06       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.